Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition - Schedule of Revenue Recognition (Details)

v3.22.2.2
Revenue Recognition - Schedule of Revenue Recognition (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Disaggregation of Revenue [Line Items]        
Total revenue $ 5,146 $ 4,574 $ 15,377 $ 12,017
Functional neurosurgery navigation and therapy        
Disaggregation of Revenue [Line Items]        
Total revenue 2,420 2,154 6,831 5,932
Functional Neurosurgery Navigation and Therapy - Disposable Products        
Disaggregation of Revenue [Line Items]        
Total revenue 2,045 2,004 5,706 5,782
Functional Neurosurgery Navigation and Therapy - Services        
Disaggregation of Revenue [Line Items]        
Total revenue 375 150 1,125 150
Biologics and drug delivery        
Disaggregation of Revenue [Line Items]        
Total revenue 2,246 2,057 6,808 5,106
Biologics and Drug Delivery - Disposable Products        
Disaggregation of Revenue [Line Items]        
Total revenue 798 1,137 2,873 2,501
Biologics and Drug Delivery - Services        
Disaggregation of Revenue [Line Items]        
Total revenue 1,448 920 3,935 2,605
Capital equipment and software        
Disaggregation of Revenue [Line Items]        
Total revenue 480 363 1,738 979
Capital Equipment and Software - Systems and Software Products        
Disaggregation of Revenue [Line Items]        
Total revenue 287 197 1,171 580
Capital Equipment and Software - Services        
Disaggregation of Revenue [Line Items]        
Total revenue $ 193 $ 166 $ 567 $ 399